Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7763-7775

  Loffredo, John T ^a   Sidney, John ^b   Bean, Alex T ^a   Beal, Dominic R ^a   Bardet, Wilfried ^c   Wahl, Angela ^c   Hawkins, Oriana E ^c   Piaskowski, Shari ^a   Wilson, Nancy A ^a   Hildebrand, William H ^c   Watkins, David I ^a,d   Sette, Alessandro ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GAG PROTEIN; HLA B27 ANTIGEN; HLA B2705 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAMU B08 ANTIGEN; UNCLASSIFIED DRUG; VPR PROTEIN; BACTERIOPHAGE T7 INDUCED DNA POLYMERASE; DNA DIRECTED DNA POLYMERASE; EPITOPE; HLA ANTIGEN CLASS 1; LIGAND; PEPTIDE; PEPTIDE LIBRARY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; DNA-DIRECTED DNA POLYMERASE; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 67649172577     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900111     Document Type: Article

References (80)

1. Pitisuttithum, P., P. Gilbert, M. Gurwith, W. Heyward, M. Martin, F. van Griensven, D. Hu, J. W. Tappero, and K. Choopanya. 2006. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194: 1661-1671.
2. Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.
3. McElrath, M. J., S. C. De Rosa, Z. Moodie, S. Dubey, L. Kierstead, H. Janes, O. D. Defawe, D. K. Carter, J. Hural, R. Akondy, et al. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372: 1894-1905.
4. Deeks, S. G., and B. D. Walker. 2007. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27: 406-416.
5. Yant, L. J., T. C. Friedrich, R. C. Johnson, G. E. May, N. J. Maness, A. M. Enz, J. D. Lifson, D. H. O'Connor, M. Carrington, and D. I. Watkins. 2006. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80: 5074-5077.
6. Loffredo, J. T., J. Maxwell, Y. Qi, C. E. Glidden, G. J. Borchardt, T. Soma, A. T. Bean, D. R. Beal, N. A. Wilson, W. M. Rehrauer, et al. 2007. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81: 8827-8832.
7. + T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation. PLoS ONE 2: e1152.
8. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219. (Pubitemid 30099526)
9. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self-peptides bound to purified HLA-B27. Nature 353: 326-329.
10. Rotzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H. G. Rammensee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39: 74-77. (Pubitemid 23320481)
11. Lopez de Castro, J. A., I. Alvarez, M. Marcilla, A. Paradela, M. Ramos, L. Sesma, and M. Vazquez. 2004. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 63: 424-445.
12. Kaslow, R. A., C. Rivers, J. Tang, T. J. Bender, P. A. Goepfert, R. El Habib, K. Weinhold, and M. J. Mulligan. 2001. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J. Virol. 75: 8681-8689.
13. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, et al. 1997. Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nat. Med. 3: 212-217.
14. Hendel, H., S. Caillat-Zucman, H. Lebuanec, M. Carrington, S. O'Brien, J. M. Andrieu, F. Schachter, D. Zagury, J. Rappaport, C. Winkler, et al. 1999. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J. Immunol. 162: 6942-6946.
15. + T cell response against HIV-1. PLoS Med. 3: e403.
16. Gao, X., A. Bashirova, A. K. Iversen, J. Phair, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, M. Altfeld, S. J. O'Brien, and M. Carrington. 2005. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med. 11: 1290-1292.
17. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54: 535-551.
18. Feeney, M. E., Y. Tang, K. A. Roosevelt, A. J. Leslie, K. McIntosh, N. Karthas, B. D. Walker, and P. J. Goulder. 2004. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 78: 8927-8930.
19. Betts, M. R., B. Exley, D. A. Price, A. Bansal, Z. T. Camacho, V. Teaberry, S. M. West, D. R. Ambrozak, G. Tomaras, M. Roederer, et al. 2005. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc. Natl. Acad. Sci. USA 102: 4512-4517.
20. + T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J. Virol. 81: 7725-7731.
21. + immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J. Virol. 82: 1723-1738.
22. Boyson, J. E., C. Shufflebotham, L. F. Cadavid, J. A. Urvater, L. A. Knapp, A. L. Hughes, and D. I. Watkins. 1996. The MHC class I genes of the rhesus monkey: different evolutionary histories of MHC class I and II genes in primates. J. Immunol. 156: 4656-4665.
23. Evans, D. T., D. H. O'Connor, P. Jing, J. L. Dzuris, J. Sidney, J. da Silva, T. M. Allen, H. Horton, J. E. Venham, R. A. Rudersdorf, et al. 1999. Virus-specific cytotoxic T lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5: 1270-1276.
24. Dzuris, J. L., J. Sidney, E. Appella, R. W. Chesnut, D. I. Watkins, and A. Sette. 2000. Conserved MHC class I peptide binding motif between humans and rhesus macaques. J. Immunol. 164: 283-291.
25. + T cell epitopes. Immunogenetics 59: 693-703.
26. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248: 1109-1112.
27. Friedrich, T. C., E. J. Dodds, L. J. Yant, L. Vojnov, R. Rudersdorf, C. Cullen, D. T. Evans, R. C. Desrosiers, B. R. Mothe, J. Sidney, et al. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10: 275-281.
28. + T cell responses are involved in durable control of AIDS virus replication. J. Virol. 81: 3465-3476.
29. Prilliman, K., M. Lindsey, Y. Zuo, K. W. Jackson, Y. Zhang, and W. Hildebrand. 1997. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics 45: 379-385.
30. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20.
31. Wahl, A., and W. H. Hildebrand. Changes in MHC Class I Peptide Epitopes Following Viral Infection. In: Methods in Molecular Biology: Modulation of Antigen Presentation During Infection. Humana Press, Totowa, NJ. In press.
32. Pinilla, C., J. R. Appel, P. Blanc, and R. A. Houghten. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. BioTechniques 13: 901-905.
33. Sidney, J., S. Southwood, C. Oseroff, M. F. del Guercio, A. Sette, and H. M. Grey. 2001. Measurement of MHC/peptide interactions by gel filtration. Curr. Protoc. Immunol. Chapter 18: Unit 18.3.
34. Sidney, J., S. Southwood, and A. Sette. 2005. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires. Immunogenetics 57: 393-408.
35. Sidney, J., M. F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H. G. Rammensee, K. Falk, O. Rotzschke, M. Takiguchi, R. T. Kubo, et al. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154: 247-259.
36. Allen, T. M., J. Sidney, M. F. del Guercio, R. L. Glickman, G. L. Lensmeyer, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, and D. I. Watkins. 1998. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160: 6062-6071.
37. Schneidewind, A., M. A. Brockman, J. Sidney, Y. E. Wang, H. Chen, T. J. Suscovich, B. Li, R. I. Adam, R. L. Allgaier, B. R. Mothe, et al. 2008. Structural and functional constraints limit options for cytotoxic T lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82: 5594-5605.
38. + T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J. Immunol. 173: 5064-5076.
39. Sette, A., J. Sidney, M. F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31: 813-822.
40. Sidney, J., E. Assarsson, C. Moore, S. Ngo, C. Pinilla, A. Sette, and B. Peters. 2008. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4: 2.
41. Sidney, J., B. Peters, C. Moore, T. J. Pencille, S. Ngo, K. A. Masterman, S. Asabe, C. Pinilla, F. V. Chisari, and A. Sette. 2007. Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library. Immunogenetics 59: 745-751.
42. + T cells is unrelated to epitope specificity and is abrogated by viral escape. J. Virol. 81: 2624-2634.
43. Hutchinson, S. L., L. Wooldridge, S. Tafuro, B. Laugel, M. Glick, J. M. Boulter, B. K. Jakobsen, D. A. Price, and A. K. Sewell. 2003. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J. Biol. Chem. 278: 24285-24293.
44. +-T lymphocyte selection in simian immunodeficiency virus sequence variation. J. Virol. 78: 14012-14022.
45. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1995. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J. Exp. Med. 181: 2097-2108.
46. Stryhn, A., L. O. Pedersen, T. Romme, C. B. Holm, A. Holm, and S. Buus. 1996. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol. 26: 1911-1918. (Pubitemid 26283169)
47. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, H. Tamamura, H. Yamagishi, K. Okumura, P. Walden, T. Suto, and T. Kawasaki. 2000. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 51: 816-828.
48. Lauemoller, S. L., A. Holm, J. Hilden, S. Brunak, M. Holst Nissen, A. Stryhn, L. Ostergaard Pedersen, and S. Buus. 2001. Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations. Tissue Antigens 57: 405-414.
49. Peters, B., H. H. Bui, S. Frankild, M. Nielson, C. Lundegaard, E. Kostem, D. Basch, K. Lamberth, M. Harndahl, W. Fleri, et al. 2006. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput. Biol. 2: e65.
50. Peruzzi, M., N. Wagtmann, and E. O. Long. 1996. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184: 1585-1590.
51. Ugrinovic, S., A. Mertz, P. Wu, J. Braun, and J. Sieper. 1997. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J. Immunol. 159: 5715-5723.
52. Kuon, W., H. G. Holzhutter, H. Appel, M. Grolms, S. Kollnberger, A. Traeder, P. Henklein, E. Weiss, A. Thiel, R. Lauster, et al. 2001. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases. J. Immunol. 167: 4738-4746.
53. Alvarez, I., M. Marti, J. Vazquez, E. Camafeita, S. Ogueta, and J. A. Lopez de Castro. 2001. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T cell antigen presentation. J. Biol. Chem. 276: 48740-48747.
54. Appel, H., W. Kuon, M. Kuhne, M. Hulsmeyer, S. Kollnberger, S. Kuhlmann, E. Weiss, M. Zeitz, K. Wucherpfennig, P. Bowness, and J. Sieper. 2004. The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes. J. Immunol. 173: 6564-6573. (Pubitemid 39541039)
55. Sidney, J., S. Southwood, V. Pasquetto, and A. Sette. 2003. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype. J. Immunol. 171: 5964-5974. (Pubitemid 37467215)
56. Sidney, J., S. Southwood, D. L. Mann, M. A. Fernandez-Vina, M. J. Newman, and A. Sette. 2001. Majority of peptides binding HLA-A*0201 with high affinity cross-react with other A2-supertype molecules. Hum. Immunol. 62: 1200-1216.
57. Lamberth, K., G. Roder, M. Harndahl, M. Nielsen, C. Lundegaard, C. Schafer-Nielsen, O. Lund, and S. Buus. 2008. The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype. Immunogenetics 60: 633-643.
58. Sylvester-Hvid, C., M. Nielsen, K. Lamberth, G. Roder, S. Justesen, C. Lundegaard, P. Worning, H. Thomadsen, O. Lund, S. Brunak, and S. Buus. 2004. SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens 63: 395-400.
59. + lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing. J. Virol. 75: 738-749.
60. Mothe, B. R., J. Sidney, J. L. Dzuris, M. E. Liebl, S. Fuenger, D. I. Watkins, and A. Sette. 2002. Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins. J. Immunol. 169: 210-219.
61. Sette, A., J. Sidney, H. H. Bui, M. F. del Guercio, J. Alexander, J. Loffredo, D. I. Watkins, and B. R. Mothe. 2005. Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. Immunogenetics 57: 53-68.
62. + T lymphocyte responses to SIVmac239. J. Immunol. 175: 5986-5997.
63. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153: 5586-5592.
64. Vitiello, A., L. Yuan, R. W. Chesnut, J. Sidney, S. Southwood, P. Farness, M. R. Jackson, P. A. Peterson, and A. Sette. 1996. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J. Immunol. 157: 5555-5562.
65. van der Most, R. G., K. Murali-Krishna, J. L. Whitton, C. Oseroff, J. Alexander, S. Southwood, J. Sidney, R. W. Chesnut, A. Sette, and R. Ahmed. 1998. Identification of Db- and Kb-restricted subdominant cytotoxic T cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240: 158-167.
66. Daza-Vamenta, R., G. Glusman, L. Rowen, B. Guthrie, and D. E. Geraghty. 2004. Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res. 14: 1501-1515.
67. Evans, D. T., P. Jing, T. M. Allen, D. H. O'Connor, H. Horton, J. E. Venham, M. Piekarczyk, J. Dzuris, M. Dykhuzen, J. Mitchen, et al. 2000. Definition of five new simian immunodeficiency virus cytotoxic T lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression. J. Virol. 74: 7400-7410.
68. Nixon, D. F., A. R. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336: 484-487.
69. Nixon, D. F., S. Huet, J. Rothbard, M. P. Kieny, M. Delchambre, C. Thiriart, C. R. Rizza, F. M. Gotch, and A. J. McMichael. 1990. An HIV-1 and HIV-2 cross-reactive cytotoxic T cell epitope. AIDS 4: 841-845.
70. Rowland-Jones, S., R. A. Colbert, T. Dong, S. McAdam, M. Brown, K. Ariyoshi, S. Sabally, H. Whittle, and A. McMichael. 1998. Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T cell epitopes presented by HLA-B*2703 and B*2705. AIDS 12: 1391-1393.
71. + T cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences. J. Virol. 82: 575-581.
72. Bennett, M. S., H. L. Ng, A. Ali, and O. O. Yang. 2008. Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity. J. Infect. Dis. 197: 390-397.
73. Draenert, R., C. L. Verrill, Y. Tang, T. M. Allen, A. G. Wurcel, M. Boczanowski, A. Lechner, A. Y. Kim, T. Suscovich, N. V. Brown, et al. 2004. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J. Virol. 78: 630-641.
74. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693-708.
75. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13: 587-622.
76. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J. Mol. Biol. 219: 277-319.
77. Rapin, N., I. Hoof, O. Lund, and M. Nielsen. 2008. MHC motif viewer. Immunogenetics 60: 759-765.
78. Peters, B., J. Sidney, P. Bourne, H. H. Bui, S. Buus, G. Doh, W. Fleri, M. Kronenberg, R. Kubo, O. Lund, et al. 2005. The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol. 3: e91.
79. Sette, A., J. Sidney, B. D. Livingston, J. L. Dzuris, C. Crimi, C. M. Walker, S. Southwood, E. J. Collins, and A. L. Hughes. 2003. Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution. Immunogenetics 54: 830-841.
80. Herberts, C. A., J. J. Neijssen, J. de Haan, L. Janssen, J. W. Drijfhout, E. A. Reits, and J. J. Neefjes. 2006. Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation. J. Immunol. 176: 2697-2701. (Pubitemid 43306927)